- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/28 - SulfonesSulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
Patent holdings for IPC class C07C 317/28
Total number of patents in this class: 280
10-year publication summary
29
|
21
|
27
|
23
|
20
|
18
|
17
|
17
|
16
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes Pharma Ireland Limited | 269 |
15 |
Olatec Therapeutics, Inc. | 61 |
11 |
Corteva Agriscience LLC | 2694 |
10 |
Acucela Inc. | 160 |
8 |
Wave Life Sciences Ltd. | 173 |
8 |
Bristol-myers Squibb Company | 4867 |
7 |
Newron Pharmaceuticals S.p.A. | 62 |
7 |
PTC Therapeutics, Inc. | 489 |
6 |
Takeda Pharmaceutical Company Limited | 2705 |
4 |
Pharmaxis Ltd | 38 |
4 |
Provincial Health Services Authority | 185 |
4 |
Quimica Sintetica, S.A. | 35 |
4 |
Temple University of the Commonwealth System of Higher Education | 626 |
4 |
The University of British Columbia | 1508 |
4 |
Lighthouse Pharmaceuticals, Inc. | 11 |
4 |
The Regents of the University of California | 20059 |
3 |
Amgen Inc. | 4106 |
3 |
Sumitomo Chemical Company, Limited | 9047 |
3 |
Shin-Etsu Chemical Co., Ltd. | 5685 |
3 |
Celgene Corporation | 1395 |
3 |
Other owners | 165 |